Skip to main content
. 2022 Nov 18;4(12):588–594. doi: 10.1253/circrep.CR-22-0109

Figure 2.

Figure 2.

Relationships between changes in HbA1c after sacubitril/valsartan treatment (∆HbA1c) and HbA1c levels before sacubitril/valsartan treatment (baseline HbA1c) in patients with diabetes. There was a correlation between ∆HbA1c and baseline HbA1c levels (y = −0.194x + 1.198; r=−0.35, P<0.05).